Molecular biologists have decoded genome of nematode living in beetles: related news

Molecular biologists have decoded genome of nematode living in beetles

Scientists at the Max Planck Institute for Developmental Biology, together with American colleagues, have decoded the genome of the Pristionchus pacificus nematode, thereby gaining insight into the evolution of parasitism.

First Whole Cancer Genome Sequenced

dooling writes "A paper detailing the sequencing of the first human cancer genome will be published in the 6 November 2008 issue of Nature. This is not only the first cancer genome published, it is the first female genome as well. You can read the paper's abstract, DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome, or the story in Science News. This issue of Nature also has articles on the sequencing of the first African and Asian genomes. The sequencing in all three articles was done using the Illumina Genome Analyzer, one of the massively parallel, next-generation genome sequencing platforms."

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

SAN DIEGO--(BUSINESS WIRE)--Oct 9, 2008 - Illumina, Inc. (NASDAQ:ILMN) today announced that the Genome Institute of Singapore (GIS), a flagship institution of Singapore and one of the top research centers in the world, has purchased four additional Genome Analyzers taking its installed base to six. Among researchers at GIS, the Genome Analyzer continues to be the preferred platform for conducting sequencing studies. The Genome Analyzers will be used in a variety of projects, including the construction of transcriptional networks linked to cancer and stem cells.

Scientists decode genome of beetle-loving nematode

illustration of this article A transatlantic research project has decoded the genome of the Pristionchus pacificus nematode. The work, carried out by the scientists at the Max Planck Institute for Developmental Biology in Germany along with their US counterparts at the National Human Genome Research Institute in St. Louis, offers the world an inside look at the evolution of parasitism, especially by raising awareness of the complex interactions between the host and parasite. Their findings were recently published in the journal Nature Genetics.

Scientists develop genome-wide platform to study how specialized proteins regulate RNA in living, intact cells

Add our medical news to StumbleUpon - Scientists develop genome-wide platform to study how specialized proteins regulate RNA in living, intact cells Add our medical news to Facebook - Scientists develop genome-wide platform to study how specialized proteins regulate RNA in living, intact cells

Nematode Genome Provides Insight Into Evolution Of Parasitism

Scientists at the Max Planck Institute for Developmental Biology, together with American colleagues, have decoded the genome of the Pristionchus pacificus nematode, thereby gaining insight into the evolution of parasitism.

Review: A Life Decoded- My Genome: My Life by Craig Venter

Scientist Craig Venter published the sequence of the human genome in 2001. A Life Decoded is his autobiography: the story of his journey from Californian surf dude through Vietnam army medic to pioneering researcher. It is a thrusting, supercaffeinated tale, in which Venter is constantly escaping death, wrestling sea snakes and succeeding with his future-oriented research against all the odds (a kind of Richard Branson of science, perhaps). As Venter used himself as a case study for mapping the human genome, the book is punctuated with discussions of how his own genetic make-up has contributed to his character. And it is a contentious character, for Venter's brash attitude and alliances with big pharmaceutical companies have stirred up strong feelings.

A new journal where molecular biology meets clinical research

The European Molecular Biology Organization (EMBO) announced the introduction of EMBO Molecular Medicine, a new journal dedicated to a research discipline focused on the interface between molecular biology and clinical research. The new journal, launching in 2009, will publish original research offering molecular insights into cellular and systemic processes underlying defined human diseases as well as potential clinical applications for diagnosis, prevention and therapy.

Scientists Sequence First Genome Of Cancer Patient

Scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots. A large research team at the Genome Sequencing Center and the Siteman Cancer Center at Washington University School of Medicine in St. Louis sequenced the genome of the patient - a woman in her 50s who ultimately died of her disease - and the genome of her leukemia cells, to identify genetic changes unique to her cancer.

Researcher sequence genome of cancer patient

For the first time, scientists have decoded the complete DNA of a cancer patient and traced her disease - acute myelogenous leukemia - to its genetic roots. A large research team at the Genome Sequencing Center and the Siteman Cancer Center at Washington University School of Medicine in St. Louis sequenced the genome of the patient - a woman in her 50s who ultimately died of her disease - and the genome of her leukemia cells, to identify genetic changes unique to her cancer.

Iran makes molecular nano-switch

Iranian scientists have successfully designed and simulated a simple but effectual butadiene-based light-sensitive molecular nano-switch. A molecular switch is a molecule that can be reversibly shifted between two or more stable states in response to various changes including light. These switches are of interest in nanotechnology and biology. Recent studies on molecular switches had focused on the discovery of molecules with various forms and conduction properties. According to the study published in Physics Letters A, butadiene is a good choice for light-sensitive molecular switches as it can convert between a trans and a cis configuration upon photoexcitation, and therefore manifest various electrical characteristics.

Illumina's human genome sequencing studies published in Nature

Illumina announced that the November 6, 2008 issue of Nature published sequencing results of the first Yoruban human genome. The study was completed by Illumina scientists and collaborators at the Wellcome Trust Sanger Institute and generated greater than 30x average coverage of the genome. Four million single-nucleotide polymorphisms (SNPs), including one million novel SNPs, and 400,000 structural variants were identified. The Yoruban study and two other papers--by researchers at Beijing Genomics Institute (BGI) and Washington University--featured in the same November 6 issue of Nature all used the Illumina Genome Analyzer to complete the sequencing studies. This marks the first time that three human genome studies--including the first Asian individual, the first cancer patient, and the first African male--have been simultaneously publis

Illumina Announces Breakthrough Human Genome Sequencing Studies Published in Nature

Three Landmark Studies of Independent Human Genomes Carried Out on Illumina Genome Analyzer SAN DIEGO--(Business Wire)-- Illumina (NASDAQ: ILMN) today announced that the November 6, 2008 issue of Nature published sequencing results of the first Yoruban human genome. The study was completed by Illumina scientists and collaborators at the Wellcome Trust Sanger Institute and generated greater than 30x average coverage of the genome. Four million single-nucleotide polymorphisms (SNPs), including one million novel SNPs, and 400,000 structural variants were identified. The Yoruban study and two other papers--by researchers at Beijing Genomics Institute (BGI) and Washington University--featured in the same November 6 issue of Nature all used the Illumina Genome Analyzer to complete the sequencing studies.

Illumina Announces Breakthrough Human Genome Sequencing Studies Published in Nature

today announced that the November 6, 2008 issue of Nature published sequencing results of the first Yoruban human genome. The study was completed by Illumina scientists and collaborators at the Wellcome Trust Sanger Institute and generated greater than 30x average coverage of the genome. Four million single-nucleotide polymorphisms (SNPs), including one million novel SNPs, and 400,000 structural variants were identified. The Yoruban study and two other papers--by researchers at Beijing Genomics Institute (BGI) and Washington University--featured in the same November 6 issue of Nature all used the Illumina Genome Analyzer to complete the sequencing studies. This marks the first time that three human genome studies--including the first Asian individual, the first cancer patient, and the first African male--have been simultaneously published

Illumina Announces Breakthrough Human Genome Sequencing Studies Published in Nature

Illumina (NASDAQ: ILMN) today announced that the November 6, 2008 issue of Nature published sequencing results of the first Yoruban human genome. The study was completed by Illumina scientists and collaborators at the Wellcome Trust Sanger Institute and generated greater than 30x average coverage of the genome. Four million single-nucleotide polymorphisms (SNPs), including one million novel SNPs, and 400,000 structural variants were identified. The Yoruban study and two other papers--by researchers at Beijing Genomics Institute (BGI) and Washington University--featured in the same November 6 issue of Nature all used the Illumina Genome Analyzer to complete the sequencing studies. This marks the first time that three human genome studies--including the first Asian individual, the first cancer patient, and the first African male--have been

Illumina Announces Breakthrough Human Genome Sequencing Studies Published in Nature

SAN DIEGO--(BUSINESS WIRE)--Nov 7, 2008 - Illumina (NASDAQ: ILMN) today announced that the November 6, 2008 issue of Nature published sequencing results of the first Yoruban human genome. The study was completed by Illumina scientists and collaborators at the Wellcome Trust Sanger Institute and generated greater than 30x average coverage of the genome. Four million single-nucleotide polymorphisms (SNPs), including one million novel SNPs, and 400,000 structural variants were identified. The Yoruban study and two other papers--by researchers at Beijing Genomics Institute (BGI) and Washington University--featured in the same November 6 issue of Nature all used the Illumina Genome Analyzer to complete the sequencing studies. This marks the first time that three human genome studies--including the first Asian individual, the first cancer patie

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

Decoded genome turns up new clues

WASHINGTON — Scientists for the first time have decoded the entire genome of a cancer patient, identifying a series of genes never before linked to the type of white blood cell cancer that ultimately killed the woman.

Molecular biologists begin deciphering stem cell differentiation

In important new work, Florida State University (FSU) molecular biologists have begun to unscramble the enormously complex process by which DNA is repackaged during differentiation - when embryonic stem cells, jacks of all cellular trades, lose their anything-goes attitude and become masters of specialized functions. As a result, scientists now are one significant step closer to the goal of stem cell therapy - to successfully convert adult tissue back to an embryo-like state so that it can be used to regenerate or replace damaged tissue.

Genome of a monkey-human malaria parasite: surprises from Plasmodium knowlesi genome sequence

Researchers have decoded the genome of a malaria parasite that has a host range from monkeys to man. Identified originally in monkeys, the parasite was first reported in a human infection just over 40 years ago.

Genome of cancer patient decoded for first time

WASHINGTON - Scientists for the first time have decoded the entire genome of a cancer patient, identifying a series of genes never before linked to the type of white blood cell cancer that ultimately killed the woman.

Genome Institute of Singapore purchases 4 additional Illumina Genome Analyzers for stem cell, cancer research studies - Quick Facts

(RTTNews) - Illumina, Inc. (ILMN: News ) announced that the Genome Institute of Singapore has purchased four additional Genome Analyzers taking its installed base to six.

Genome Institute of Singapore Purchases Four Additional Illumina Genome Analyzers to Advance Stem Cell and Cancer Research Studies

SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced that the Genome Institute of Singapore (GIS), a flagship institution of Singapore and one of the top research centers in the world, has purchased four additional Genome Analyzers taking its installed base to six. Among researchers at G

Search took 0.10 seconds.